JP2005518783A5 - - Google Patents

Download PDF

Info

Publication number
JP2005518783A5
JP2005518783A5 JP2003534569A JP2003534569A JP2005518783A5 JP 2005518783 A5 JP2005518783 A5 JP 2005518783A5 JP 2003534569 A JP2003534569 A JP 2003534569A JP 2003534569 A JP2003534569 A JP 2003534569A JP 2005518783 A5 JP2005518783 A5 JP 2005518783A5
Authority
JP
Japan
Prior art keywords
seq
factor viii
polypeptide
sequence
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003534569A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005518783A (ja
JP4634036B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/033403 external-priority patent/WO2003031598A2/en
Publication of JP2005518783A publication Critical patent/JP2005518783A/ja
Publication of JP2005518783A5 publication Critical patent/JP2005518783A5/ja
Application granted granted Critical
Publication of JP4634036B2 publication Critical patent/JP4634036B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

JP2003534569A 2001-10-05 2002-10-07 高レベルエキスプレッサー第ｖｉｉｉ因子ポリペプチドをコードする核酸配列およびアミノ酸配列および使用方法 Expired - Lifetime JP4634036B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32738801P 2001-10-05 2001-10-05
PCT/US2002/033403 WO2003031598A2 (en) 2001-10-05 2002-10-07 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010210204A Division JP5162635B2 (ja) 2001-10-05 2010-09-17 高レベルエキスプレッサー第ｖｉｉｉ因子ポリペプチドをコードする核酸配列およびアミノ酸配列および使用方法

Publications (3)

Publication Number Publication Date
JP2005518783A JP2005518783A (ja) 2005-06-30
JP2005518783A5 true JP2005518783A5 (enExample) 2006-01-12
JP4634036B2 JP4634036B2 (ja) 2011-02-16

Family

ID=23276347

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003534569A Expired - Lifetime JP4634036B2 (ja) 2001-10-05 2002-10-07 高レベルエキスプレッサー第ｖｉｉｉ因子ポリペプチドをコードする核酸配列およびアミノ酸配列および使用方法
JP2010210204A Expired - Lifetime JP5162635B2 (ja) 2001-10-05 2010-09-17 高レベルエキスプレッサー第ｖｉｉｉ因子ポリペプチドをコードする核酸配列およびアミノ酸配列および使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010210204A Expired - Lifetime JP5162635B2 (ja) 2001-10-05 2010-09-17 高レベルエキスプレッサー第ｖｉｉｉ因子ポリペプチドをコードする核酸配列およびアミノ酸配列および使用方法

Country Status (9)

Country Link
US (3) US7635763B2 (enExample)
EP (1) EP1572889B1 (enExample)
JP (2) JP4634036B2 (enExample)
AT (1) ATE417618T1 (enExample)
AU (1) AU2002337901B2 (enExample)
CA (1) CA2461443C (enExample)
DE (1) DE60230456D1 (enExample)
ES (1) ES2319745T3 (enExample)
WO (1) WO2003031598A2 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7560107B2 (en) * 1996-06-26 2009-07-14 Emory University Modified factor VIII
EP1572889B1 (en) * 2001-10-05 2008-12-17 Expression Therapeutics, LLC Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
US7709224B2 (en) 2003-06-03 2010-05-04 Biosante Pharmaceuticals, Inc. Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
US7485291B2 (en) 2003-06-03 2009-02-03 Cell Genesys, Inc. Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
WO2005107776A1 (en) * 2004-05-03 2005-11-17 Emory University METHOD OF ADMINISTERING PORCINE B-DOMAINLESS fVIII
LT1824988T (lt) 2004-11-12 2017-10-25 Bayer Healthcare Llc Nukreipta į užduotą saitą fviii modifikacija
KR101841870B1 (ko) * 2008-05-16 2018-03-23 바이엘 헬스케어 엘엘씨 표적화 응고 인자 및 그의 사용 방법
EP2635297B1 (en) 2010-11-05 2019-02-27 Baxalta GmbH A new variant of antihemophilic factor viii having increased specific activity
KR102110736B1 (ko) 2011-07-08 2020-05-14 바이오버라티브 테라퓨틱스 인크. Viii 인자 키메라 및 하이브리드 폴리펩타이드, 그리고 이들의 사용 방법
WO2014008172A2 (en) * 2012-07-03 2014-01-09 Expression Therapeutics, Llc High yield suspension cell line, system and method for making same
LT3013855T (lt) * 2013-06-24 2021-01-25 Xiao, Weidong Mutavusio viii faktoriaus kompozicijos ir metodai
CN115094062A (zh) * 2015-04-16 2022-09-23 埃默里大学 用于肝脏中蛋白质表达的重组启动子和载体及其用途
MX2018005969A (es) 2015-11-13 2018-11-29 Baxalta Inc Vectores virales que codifican variantes del factor fviii recombinantes con mayor expresión para la terapia génica de hemofilia a.
EA202190827A1 (ru) 2015-11-13 2021-11-30 Баксалта Инкорпорейтед Вирусные векторы, кодирующие рекомбинантные варианты fviii с повышенной экспрессией для генной терапии гемофилии a
KR102450833B1 (ko) 2016-04-15 2022-10-05 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 혈우병 a 치료용 유전자 요법
US20200360441A1 (en) 2017-08-23 2020-11-19 Wake Forest University Health Sciences Post-natal transplantation of factor viii-expressing cells for treatment of hemophilia
EP3672605B1 (en) 2017-08-23 2024-10-23 Wake Forest University Health Sciences In utero transplantation of factor viii-expressing cells for treatment of hemophilia
KR20210034013A (ko) 2018-07-16 2021-03-29 박스알타 인코퍼레이티드 발현이 증가된 재조합 fviii 변이체들을 인코딩하는 바이러스 벡터를 이용한 혈우병의 유전적 치료법
TWI851647B (zh) 2019-01-16 2024-08-11 日商武田藥品工業股份有限公司 用於a型血友病基因治療之編碼表現增加之重組fviii變異體的病毒載體
US11680109B2 (en) 2019-05-29 2023-06-20 Duke University Compositions and methods for detection and measurement of RNA modifications through targeted RNA editing
WO2022165390A1 (en) * 2021-01-29 2022-08-04 Expression Therapeutics, Llc Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663060A (en) * 1992-04-07 1997-09-02 Emory University Hybrid human/animal factor VIII
US6180371B1 (en) * 1996-06-26 2001-01-30 Emory University Modified factor VIII
US5888974A (en) * 1992-04-07 1999-03-30 Emory University Hybrid human/animal factor VIII
US6376463B1 (en) * 1992-04-07 2002-04-23 Emory University Modified factor VIII
US5364771A (en) * 1992-04-07 1994-11-15 Emory University Hybrid human/porcine factor VIII
US5859204A (en) * 1992-04-07 1999-01-12 Emory University Modified factor VIII
US5744446A (en) * 1992-04-07 1998-04-28 Emory University Hybrid human/animal factor VIII
CA2162497A1 (en) * 1993-06-10 1994-12-22 Sheila Connelly Adenoviral vectors for treatment of hemophilia
US6818439B1 (en) * 1994-12-30 2004-11-16 Chiron Corporation Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia and other disorders
US6458563B1 (en) * 1996-06-26 2002-10-01 Emory University Modified factor VIII
JP2002517180A (ja) * 1997-12-05 2002-06-18 ジ・イミユーン・リスポンス・コーポレーシヨン 増大された発現を示す新規ベクターおよび遺伝子
US6200560B1 (en) * 1998-10-20 2001-03-13 Avigen, Inc. Adeno-associated virus vectors for expression of factor VIII by target cells
EP1572889B1 (en) * 2001-10-05 2008-12-17 Expression Therapeutics, LLC Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use

Similar Documents

Publication Publication Date Title
JP5162635B2 (ja) 高レベルエキスプレッサー第ｖｉｉｉ因子ポリペプチドをコードする核酸配列およびアミノ酸配列および使用方法
JP2005518783A5 (enExample)
JP4361786B2 (ja) 操作されたジスルフィド結合を有する安定化蛋白質
RU2285724C2 (ru) Рекомбинантная молекула днк, кодирующая модифицированный свиной фактор viii (pol 1212), экспрессирующие векторы, модифицированный свиной фактор viii, терапевтическая композиция, способы получения белка модифицированного свиного фактора viii (варианты) и линии клеток (варианты)
DK1129186T4 (da) Et faktor VIII-polypeptid med faktor VIII:C-aktivitet
AU2002337901A1 (en) Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use
EP1424344A1 (en) Modified cDNA factor VIII and its derivates
AU2001292861A1 (en) Modified factor VIII
AU2001238416A1 (en) Modified factor VIII
JP7626514B2 (ja) 改善された薬物動態を有する、グリコシル化ｖｗｆ融合タンパク質
AU2002364509A1 (en) Factor viii c2 domain variants
AU606925B2 (en) A method for producing factor viii in high yield
JP4804356B2 (ja) 第ＶＩＩＩ因子及びその誘導体の高発現レベルのための改変されたｃＤＮＡ
EP1502921A1 (en) Recombinant mutated human factor VIII (FVIII) with improved stability
HK1080517B (en) Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
EP1454916A1 (en) Modified cDNA factor VIII and its derivatives